World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 November 2012
Main ID:  NCT01114347
Date of registration: 30/04/2010
Primary sponsor: Centre Hospitalier Universitaire de Nimes
Public title: Prevention of Nosocomial E. Coli Infections After Placement of an Indwelling Catheter During Pelvic Surgery: an Evaluation of Cranberry Gel Capsules NosoPink
Scientific title: Prevention of Nosocomial Escherichia Coli Infections After Placement of an Indwelling Catheter During Pelvic Surgery: a Randomized, Prospective, Double Blind Study for the Evaluation of Cranberry (Vaccinium Macrocarpon) Gel Capsules
Date of first enrolment: June 2010
Target sample size: 180
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01114347
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention  
Countries of recruitment
France
Contacts
Name:   Vincent Letouzey, MD
Address: 
Telephone: 33.4.66.68.32.16
Email: vincent.letouzey@chu-nimes.fr
Affiliation: 
Name:   Vincent Letouzey, MD
Address: 
Telephone:
Email:
Affiliation:  Centre Hospitalier Universitaire de Nîmes
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patient is cared for by the department of the Gynecology at the Nîmes Unversity
Hospital

- The patient is programmed for surgery with placement an indwelling catheter for 48
hours with a sterile urinary cytobacteriologic exam at inclusion

Exclusion Criteria:

- the urinary cytobacteriologic exam at inclusion is positive

- the patient is taking antivitamin K

- the patient is taking antibiotics

- history of urolithiasis

- the patient refuses to participate

- the patient is pregnant or nursing

- the patient is not associated with a social security system (no insurance)

- the patient is under guardianship



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Bacteriuria
Cross Infection
Intervention(s)
Dietary Supplement: cranberry type A pro anthocyandines
Dietary Supplement: Placebo
Primary Outcome(s)
Presence/absence of Asymptomatic bacteriuria [Time Frame: 15 days post-op]
Secondary Outcome(s)
Secondary ID(s)
2008-AO1604-51
AOI/2009/VL-01
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history